Nel ASA's $12 Million US Order Won't Ship Until 2027 — and That Timing Is the Whole Story
Published on 10/16/2026 at 18:01 | Editorial boerse-global.de
Nel ASA has booked another US contract, but the calendar matters as much as the customer. Nel Hydrogen US, a subsidiary of the Norwegian electrolyser maker, secured an order worth roughly USD 12 million from an unnamed American technology group with global operations. Containerised PEM electrolysers and associated services are covered, with delivery slated for 2027.
That is a firm purchase order rather than a memorandum of understanding — a distinction worth holding onto. It also means the revenue lands in a future period, not the one just reported. Demand for Nel's equipment is evidently there; what the order does not do is answer how the top line behaves between now and the handover.
A quarter that pulls in two directions
The figures released yesterday for the third quarter of 2026 capture that tension precisely. Revenue from customer contracts fell 63% year on year to NOK 112 million, while the net loss widened to NOK 141 million from NOK 85 million in the same period a year earlier.
Order intake moved the other way entirely, surging 339% to NOK 253 million. The backlog closed the quarter at NOK 1,314 million, up 34% on the prior-year level. PEM technology accounted for 97% of the intake, concentrating recovery hopes in a single business line.
Should investors sell immediately? Or is it worth buying Nel ASA?
So the order book is expanding even as the income statement deteriorates. A fuller pipeline signals future business; it neither substitutes for delivery nor for the revenue that follows. That gap is the crux of how the quarter should be read.
Shares drew modest support from the news, adding 1.1% on the day. That is hardly confirmation of a turnaround — if anything, it hands investors the harder question of how much credit to extend to order execution that has not yet happened.
PEM is carrying the story
There is one place where the improved demand has already reached the accounts. PEM revenue climbed to NOK 89 million, a 65% increase over the prior-year quarter. Here, new orders and growing business sit side by side rather than in opposition.
Concrete customer wins underpin that. Collins Aerospace placed an order in September for equipment worth about USD 20 million. Tuesday's US contract, at roughly USD 12 million, followed. Both point to future revenue rather than immediate relief.
The optimistic case rests on Nel working through its PEM backlog on schedule and sustaining that revenue trajectory. If it does, the segment could increasingly offset weakness elsewhere. What would make the case genuinely persuasive is higher revenue arriving alongside smaller losses — that combination alone would demonstrate the stronger demand carries economic weight beyond the order entry line.
The alkaline drag is not small
The bear case has solid footing. Revenue from alkaline electrolysers collapsed to NOK 23 million, down 91% from a year earlier. PEM growth has not been enough to absorb that shortfall.
An uneven recovery is therefore the live risk. Even consistently strong PEM orders would first have to compensate for a severe slump in the alkaline business. The wider net loss meanwhile shows the better order picture has yet to coincide with improved earnings.
The Herøya line has been idle since January 2025. A new line with 1 GW of annual capacity is planned — capacity that cannot yet be counted as an available growth driver. At quarter-end, Nel held roughly NOK 1.08 billion in liquidity. That belongs to the financial starting position; it is not evidence of operational stabilisation, and without guidance on future cash consumption no reliable funding runway can be derived from it.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
Rheinmetall talks sit in a different category
The letter of intent with Rheinmetall belongs in the same sorting exercise. The two companies intend to explore options for decentralised production of renewable synthetic fuels, combining Nel's electrolyser technology with Rheinmetall's Giga-PtX concept and its integration expertise.
The arrangement is explicitly non-binding. Unlike the US order, it centres on examining business opportunities rather than executing them. For investors, a clear hierarchy emerges: firm orders, expected deliveries and non-committal intentions should not be treated as equivalents. What ultimately matters for a business recovery is the conversion of orders into revenue.
2027 becomes the test
As long as PEM demand holds and Nel converts it into rising sales, a gradual recovery stays plausible — and shrinking losses would reinforce that view. If revenue conversion lags order intake, the larger backlog loses its force as an argument for a turn.
The dated checkpoint is the 2027 delivery to the new US customer. Until then, each set of results will be judged on one thing above all: whether Nel closes the distance between orders and revenue. The investment question, in other words, is not the size of any single order spike but what the company does with it.
Ad
Nel ASA Stock: New Analysis - 16 October
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
